Dr. Esteva on Next-Generation Sequencing in Metastatic Breast Cancer

Francisco J. Esteva, MD, PhD
Published: Friday, Sep 08, 2017



Francisco J. Esteva, MD, PhD, medical oncologist, NYU Langone Medical Center, discusses next-generation sequencing in metastatic breast cancer.

Next-generation sequencing is not yet recommended as the standard of care by the FDA, though it is used at many large institutions.

Esteva says that the goal with this sequencing would allow treating physicians to direct their patients to appropriate clinical trials.
 
SELECTED
LANGUAGE


Francisco J. Esteva, MD, PhD, medical oncologist, NYU Langone Medical Center, discusses next-generation sequencing in metastatic breast cancer.

Next-generation sequencing is not yet recommended as the standard of care by the FDA, though it is used at many large institutions.

Esteva says that the goal with this sequencing would allow treating physicians to direct their patients to appropriate clinical trials.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 1st Annual Paris Breast Cancer Conference™Dec 31, 20181.5
35th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow® Clinical Vignette SeriesJan 31, 20192.0
Publication Bottom Border
Border Publication
x